Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology USA
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Growth Hormone Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA
Efforts for early detection of atrial fibrillation and cardioembolic stroke prevention
Release Date:
Review Process: Expert Review Panel
Quality Improvement Internal Medicine Japan
Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medical
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Patient Registries In ATTR-CM
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Japan
Optimizing Menopausal Symptom Management in Canada
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Canada
Optimizing Menopausal Symptom Management in Canada
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Canada
Gene and Anti-TFPI Therapies in Hemophilia
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Implementing Updated Pneumococcal Immunization Recommendations in Adults
Release Date:
Review Process: Pfizer Internal
Quality Improvement Vaccines USA
Employment support / Lung Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Biomarker Testing / Lung Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom
Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan